EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uso de Levomepromazina en unidades de cuidados intensivos pediátricos de la república argentina: Encuesta sobre perfil de indicaciones

Eugenia Teran, Matias Daniel Cattoni, Franco Ezequiel Garcia, Marcela Passanisi, Maria del Pilar Arias Lopez

Revista Argentina de Terapia Intensiva · 19.03.2026 · 43

DOI: 10.64955/29v59x33 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Argentina de Terapia Intensiva, online erschienen am 19.03.2026. Verfasst von Eugenia Teran und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To describe the use of levomepromazine in pediatric intensive care units (PICUs) across Argentina.

Design

Structured survey distributed via email and instant phone messaging to healthcare professionals working in pediatric intensive care units, including physicians, nurses, physical therapists, and pharmacists.

Setting

Public and private hospitals, either general or specialized in pediatric care.

Participants

All staff members actively engaged in clinical care within PICUs were invited to participate.

Intervention

None.

Results

A total of 116 responses were obtained from 154 professionals invited to participate (response rate 75%) from 13 PICUs nationwide. Levomepromazine was most commonly indicated as an adjuvant in analgesic sedation (49.7%), followed by its use in the treatment of delirium (37%), and as an antipsychotic-neuroleptic agent, while 3.2% employed it as a first-line agent for analgesic sedation or as an antiemetic. Since respondents could select more than one indication, the percentages are not mutually exclusive Conclusions: Ninety-three percent of respondents reported regular use of levomepromazine in their units, suggesting that this drug is frequently and widely used in the surveyed PICUs.

Zitieren

APA

Teran, E., Cattoni, M. D., Garcia, F. E., Passanisi, M., & Lopez, M. D. P. A. (2026). Uso de Levomepromazina en unidades de cuidados intensivos pediátricos de la república argentina: Encuesta sobre perfil de indicaciones. Revista Argentina de Terapia Intensiva, 43. https://doi.org/10.64955/29v59x33

Vancouver

Teran E, Cattoni MD, Garcia FE, Passanisi M, Lopez MDPA. Uso de Levomepromazina en unidades de cuidados intensivos pediátricos de la república argentina: Encuesta sobre perfil de indicaciones. Revista Argentina de Terapia Intensiva. 2026;43. doi:10.64955/29v59x33

BibTeX
@article{Teran2026,
  author = {Teran, Eugenia and Cattoni, Matias Daniel and Garcia, Franco Ezequiel and Passanisi, Marcela and Lopez, Maria del Pilar Arias},
  title = {Uso de Levomepromazina en unidades de cuidados intensivos pediátricos de la república argentina: Encuesta sobre perfil de indicaciones},
  journal = {Revista Argentina de Terapia Intensiva},
  year = {2026},
  volume = {43},
  doi = {10.64955/29v59x33}
}
Kostenlos starten →